DRI-ecstasy plus mdma/MDA reagent

Ended Awarded

Contract number
N6854621F3012
Awardee
Awarding agency
Obligated
$8,026

Award facts

Contract value 100% obligated
$8,026.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fremont, CA 94538, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of the Navy Bureau of Medicine and Surgery awarded an $8,026 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA REAGENT. Microgenics, a division of Thermo Electron Corporation, will deliver the requested drug identification and screening reagents to the place of performance in Fremont, California by the March 10, 2021 completion date. No set aside designation was applied to this award to support the Navy's medicine and surgery programs.

Quick answers

Who was awarded contract N6854621F3012?

N6854621F3012 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on March 1, 2021.

How much is contract N6854621F3012 worth?

The government has obligated $8,026 on N6854621F3012.

Is contract N6854621F3012 an order under another contract?

Yes. N6854621F3012 is a delivery order under N6264519D5003, an indefinite delivery contract.

Was contract N6854621F3012 competed?

The extent of competition for N6854621F3012 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award